SkyAI, Inc.

NASDAQ:STSS

Medical - Instruments & Supplies

Healthcare
$1.32 +0.00%

+$0.00 today

Market cap
$55.65M
Beta
2.02
P/E (TTM)
1.3
EPS (TTM)
$0.91
52W Low $1.09High $18.23

Volume 0.00M

Average 0.37M

STSS Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

SkyAI, Inc.NASDAQ: STSS

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation grows, but more slowly than its trailing trend

Q1 FY2026 stock-based compensation of $2.23M rose 4924.9% year over year, behind the +24888.0% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 10.9% from the prior quarter. Over 3 fiscal years it compounded at +373.5% a year.

Context

  • Stock-based compensation amounted to 52649.5% of revenue in FY2025.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +4924.9% toward the trailing-twelve-month pace of +24888.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.23M-10.9% QoQ
Last fiscal yearDec 2025
$107.47M+20534.0% YoY
LTMMar 2026
$109.65M+24888.0% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4924.9%——
1 year+20534.0%——
3-year CAGR+373.5%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
107.47M USD
Year-over-year change
+20534.0%
4-year CAGR
+207.9%

Stock-Based Compensation vs competitors

How STSS compares with its peers on the latest reported figures

  • STSS's LTM Mar 2026 stock-based compensation of $109.65M is the 2nd largest of the 10 companies compared; the peer median is $1.83M.
  • Its year-over-year change of +24888.0% is the 2nd highest of 10, against a peer median of -34.7%.
  • Stock-based compensation amounts to 27627.6% of revenue for STSS, versus a peer median of 12.3%.
STSS Competitors Peer median
Stock-Based Compensation for STSS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LUCDLucid Diagnostics Inc.LTM Mar 2026$2.3B +49501.8%-33.1%44751.8%
STSSSkyAI, Inc.LTM Mar 2026$109.65M +24888.0%+373.5%27627.6%
GLSIGreenwich LifeSciences, Inc.LTM Mar 2026$4.63M -43.5%+57.4%—
SERASera Prognostics, Inc.LTM Mar 2026$4.45M -34.7%+0.4%7810.5%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$4.21M +10.0%+0.1%12.3%
CGTXCognition Therapeutics, Inc.LTM Mar 2026$1.83M -42.1%-16.4%—
MBOTMicrobot Medical Inc.LTM Mar 2026$1.02M -11.2%-15.5%974.3%
PDEXPro-Dex, Inc.LTM Mar 2026$665K +59.1%-24.2%0.9%
JYNTThe Joint Corp.LTM Mar 2026$657.28K -55.6%+0.6%1.2%
CCLDCareCloud, Inc.LTM Mar 2026$67K -92.8%-54.8%0.1%
Peer median (excluding STSS) $1.83M-34.7%-15.5%12.3%

Competitors are the stored peer set for STSS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(4.66M)(4.64M)(9.84M)(9.3M)(270.34M)
Depreciation & Amortization28.7K654.57K882.18K773.9K132.54K
Deferred Income Tax00(30K)(30K)0
Stock-Based Compensation1.2M1.01M963.02K520.83K107.47M
Change in Working Capital112.64K(209.22K)(1.12M)(426.18K)2.79M
Accounts Receivables0000(204.12K)
Inventory(121.99K)(34.11K)(1.44M)(350.56K)(298.24K)
Accounts Payables202.89K(104.35K)415.51K11.94K238.45K
Other Working Capital31.74K(70.75K)(94.9K)(87.56K)3.05M
Other Non-Cash Items179.52K(3.25M)639.99K1.53M143.23M
Operating Cash Flow(3.15M)(6.43M)(8.51M)(6.93M)(16.72M)
Capital Expenditures(2.27M)(752.34K)(698.28K)(138.8K)3
Acquisitions (Net)00000
Purchases of Investments0(209.68K)000
Sales of Investments00000
Other Investing Activities(75K)(2.16M)0(1.02M)(18.64M)
Investing Cash Flow(2.34M)(3.12M)(698.28K)(1.16M)(189.16M)
Debt Repayment1.8M(2M)02.53M3.41M
Common Stock Issued3.38M14.2M8.03M3.37M212.1M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities032.5K000
Financing Cash Flow5.18M12.24M8.03M5.91M215.51M
Effect of Forex Changes07.33K17.96K36.41K(250K)
Net Change in Cash(311.04K)2.69M(1.16M)(2.15M)9.38M
Free Cash Flow(5.42M)(7.19M)(9.21M)(7.07M)(16.72M)

SkyAI, Inc.

NASDAQ:STSS

Intrinsic Alpha fair value

Locked

Current Price

$1.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.